NEW YORK, March 3, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Teladoc Health, Inc. ("Teladoc" or the "Company") (NYSE: TDOC). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.The investigation concerns whether Teladoc and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining the class action] On February 20, 2025, B ...

Core Insights - Teladoc's stock experienced a significant decline following the release of its fourth-quarter results, with a drop of 11.7% noted during trading [1] - The company's Q4 report was mixed, showing sales that exceeded Wall Street expectations but a larger-than-expected loss [2] Financial Performance - In Q4, Teladoc reported a revenue decline of 3% year over year, totaling $640.49 million, while the loss per share was $0.28, compared to a consensus estimate of a $0.22 loss on $639.44 million in revenue [3] - The integrated care customer count increased by 5% year over year, but average revenue per user fell by 2%, indicating weakening pricing power [4] Future Guidance - For the current year, Teladoc projects sales between $2.468 billion and $2.576 billion, suggesting a potential decline of approximately 1.9% from last year's sales of around $2.57 billion [5] - The company anticipates an annual loss per share between $0.50 and $1.10, which is an improvement from last year's loss of $5.87 per share [5] Strategic Challenges - Despite efforts to cut costs and reduce losses, Teladoc's growth has stalled, and there is uncertainty regarding future catalysts for growth [6] - The company has faced challenges due to previous acquisitions and significant write-downs, complicating its path to profitability and sustainable sales growth [6]

Telehealth Services and Membership - Teladoc Health completed approximately 17.3 million telehealth visits in 2024 through B2B and D2C channels[15]. - As of December 31, 2024, approximately 94 million members in the U.S. have access to Teladoc's products and services[18]. - The platform supports upwards of 100,000 visits per day and is designed for quick introduction of new clinical and digital services[37]. - Teladoc aims to grow its client and membership base while deepening engagement and usage of service offerings[26]. - The mobile app serves as a foundational tool for member engagement, providing access to all virtual health services in a user-friendly experience[55]. Revenue Generation and Financial Performance - For the year ended December 31, 2024, 86% of consolidated revenue was derived from access fees[19]. - The Integrated Care segment generates revenue primarily on a contractually recurring, access fee basis, with clients paying on a PMPM or PPPM model[20]. - The BetterHelp segment primarily generates revenue from paying users who pay a weekly or monthly fee for access to therapists[23]. - BetterHelp accounted for 41% of total consolidated revenue in 2024[193]. - The company estimates significant growth potential within existing clients, as current membership represents only a portion of potential beneficiaries[58]. - The company expects to derive a significant portion of revenue from the renewal of existing client contracts and sales of additional applications and services[138]. Market and Competitive Landscape - The virtual care market is developing and volatile, with uncertainty regarding sustained demand and consumer acceptance impacting future growth[130]. - The company faces increased competition in the virtual care market, which may lead to pricing pressures and impact sales and profitability[136]. - The company anticipates that the demand for employer-sponsored healthcare may decline, which could adversely affect its revenue model[155]. - The company is executing growth initiatives, including the expansion of BetterHelp into international markets, but faces risks related to the successful implementation of these strategies[160]. Regulatory and Compliance Issues - Regulatory changes during the COVID-19 pandemic have increased access to telehealth services, including higher reimbursement rates and elimination of prior authorization requirements[79]. - The company has established systems to ensure that affiliated providers are appropriately licensed under applicable state laws for telehealth services[81]. - The Stark Law imposes penalties of up to $29,899 per violation and potential exclusion from federally funded healthcare programs for improper referrals[85]. - Violations of the Anti-Kickback Statute can result in civil monetary penalties of up to $120,816 and criminal fines of $100,000 per violation[87]. - The False Claims Act allows for fines ranging from $13,058 to $27,018 for each false claim, with potential damages up to three times the amount sustained by the federal government[88]. - HIPAA violations can lead to significant civil and criminal penalties, including fines and potential exclusion from government programs[90]. Operational and Strategic Initiatives - The company continues to expand its virtual primary care offering, Primary360, targeting commercial health plans and employers in the U.S.[51]. - Investments in chronic care management and mental health services, such as myStrength Complete and Chronic Care Complete, are ongoing to enhance patient outcomes[53]. - The company has enhanced its talent development programs, including online courses and executive succession planning, to support employee growth[114]. - The company is focused on building a diverse workforce and has implemented initiatives to promote diversity in hiring and employee engagement[116]. - The company is reliant on a limited number of third-party suppliers, which poses risks of supply chain disruptions and cost inflation[122]. Financial Health and Capital Requirements - The company reported a history of losses and an accumulated deficit, raising concerns about achieving profitability in the future[122]. - The company incurred net losses of $1,001.2 million and $220.4 million for the years ended December 31, 2024 and 2023, respectively, with an accumulated deficit of $16,229.9 million as of December 31, 2024[124]. - The company may need to raise additional capital through debt or equity financings to fund operations due to cash flow needs[124]. - The company may need to incur additional indebtedness or seek capital through new equity or debt financings to support growth[195]. Cybersecurity and Data Privacy - The company faces risks related to cybersecurity measures that could expose confidential information of clients or members[122]. - The company has experienced cybersecurity incidents in the past, which have not resulted in material impacts, but ongoing threats require additional resources for security measures[209]. - The company maintains a security and privacy damages insurance policy, but coverage may not be adequate for all potential losses[206]. - The company must navigate various international risks, including regulatory compliance and cultural differences, as it expands its operations[179]. Employee and Workforce Management - As of December 31, 2024, the company employed approximately 5,500 people, with 84% being full-time employees and 16% part-time employees[111]. - The company faces intense competition in the job market for qualified professionals, impacting its ability to attract and retain talent[187]. - Volatility in stock price may adversely affect the company's ability to attract or retain highly skilled personnel[188]. - The company may experience difficulties in hiring and retaining skilled personnel due to limited qualified candidates in the healthcare market[187]. Economic and Market Risks - Economic downturns and market volatility may impair clients' ability to make timely payments, adversely affecting the company's revenue[168]. - The company anticipates that economic conditions may lead to increased write-offs of accounts receivable if clients struggle to pay for services[170]. - Fluctuations in quarterly results are expected due to upfront costs associated with client contracts, impacting the recognition of revenue over time[172]. - Seasonal trends affect membership and utilization rates, with the highest visit and revenue levels typically occurring in the first and fourth quarters[73].

Michael Wiggins De Oliveira is an inflection investor. This means buying into cheap companies at the moment when their narrative is changing and the business is on a path toward becoming significantly more profitable over the next year.With a focus on tech and “the Great Energy Transition (including uranium)”, Michael runs a concentrated portfolio with approximately 15 to 20 stocks and an average holding period of 18 months. Through his 10+ years analyzing countless companies, Michael has accumulated outsta ...

Teladoc Health, Inc. (NYSE:TDOC) Q4 2024 Earnings Conference Call February 26, 2025 4:30 PM ET Company Participants Michael Minchak - Head of Investor Relations Chuck Divita - Chief Executive Officer Mala Murthy - Chief Financial Officer Conference Call Participants Lisa Gill - J.P. Morgan Jessica Tassan - Piper Sandler David Roman - Goldman Sachs Sean Dodge - RBC Richard Close - Cannacord Genuity Daniel Grosslight - Citi Jailendra Singh - Truist George Hill - Deutsche Bank Charles Rhyee - TD Cowen Michael ...

For the quarter ended December 2024, Teladoc (TDOC) reported revenue of $640.49 million, down 3% over the same period last year. EPS came in at -$0.28, compared to -$0.17 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $639.5 million, representing a surprise of +0.16%. The company delivered an EPS surprise of -33.33%, with the consensus EPS estimate being -$0.21.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and ho ...

Teladoc (TDOC) came out with a quarterly loss of $0.28 per share versus the Zacks Consensus Estimate of a loss of $0.21. This compares to loss of $0.17 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -33.33%. A quarter ago, it was expected that this telehealth services provider would post a loss of $0.29 per share when it actually produced a loss of $0.19, delivering a surprise of 34.48%.Over the last four quarters, the compan ...

Teladoc Health reported weak fourth-quarter results as challenges in its BetterHelp segment weighed down gains elsewhere in the business.Teladoc Health (TDOC -1.70%), a leader in telehealth services, released its fourth-quarter earnings on Feb. 26. The company reported revenue of $640.5 million, just above the $639 million that analysts had expected, but 3% lower than the same quarter last year. Its net loss per share was $0.28, worse than the loss of $0.26 per share that analysts had anticipated. MetricQ4 ...

Core Viewpoint - Teladoc Health reported a wider loss than expected and provided disappointing guidance for the upcoming quarter, leading to a decline in its stock price [1][2]. Financial Performance - Revenue decreased by 3% in Q4 to $640.5 million compared to $660.5 million in the same period last year [1][6]. - Net loss widened to $48.4 million, or 28 cents per share, from a loss of $28.9 million, or 17 cents per share, a year ago [1]. - Adjusted earnings fell by 35% to $74.8 million in Q4, with the Integrated Care segment down 5% to $53.2 million and BetterHelp's adjusted earnings dropping 63% to $21.7 million [3]. Future Guidance - For Q1, Teladoc expects revenue between $608 million and $629 million, below analysts' expectations of $632.9 million [4]. - Adjusted earnings for the first quarter are projected to be between $47 million and $59 million [4]. Strategic Moves - Teladoc announced the acquisition of preventative care company Catapult Health for $65 million, which is expected to contribute to future growth [5].

4Q-24 Quarterly Results Cautionary Note 2 • This presentation contains, and the officers of Teladoc Health, Inc. (the "Company" or "Teladoc Health") may make, "forward-looking" statements that are based on management's beliefs and assumptions and on information currently available to management. These forward-looking statements include, without limitation, information concerning possible or assumed future results of operations, including descriptions of the Company's business plan and strategies. These stat ...